Vir Biotechnology Inc (VIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,518,330 | 826,757 | 356,409 | 720,633 | 748,955 |
| Marketable Securities | 690,520 | 447,719 | 360,330 | 224,929 | 84,107 |
| Receivables | 7,000 | 1,223,161 | 773,079 | 93,003 | N/A |
| TOTAL | $2,288,267 | $2,567,548 | $1,562,821 | $1,066,337 | $862,295 |
| Non-Current Assets | |||||
| PPE Net | 85,135 | 65,583 | 42,834 | 26,610 | 20,251 |
| Investments And Advances | 97,585 | 103,535 | 201,388 | 0 | 50,680 |
| Intangibles | 49,958 | 50,091 | 50,224 | 50,358 | 50,491 |
| Other Non-Current Assets | 98,049 | 100,372 | 97,001 | 66,908 | 73,864 |
| TOTAL | $330,727 | $319,581 | $391,447 | $143,876 | $195,286 |
| Total Assets | $2,618,994 | $2,887,129 | $1,954,268 | $1,210,213 | $1,057,581 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,618 | 10,955 | 6,521 | 4,225 | 11,032 |
| Accrued Expenses | 354,086 | 577,669 | 236,512 | 64,845 | 64,074 |
| Other current liabilities | N/A | N/A | N/A | 68,500 | 26,200 |
| TOTAL | $477,868 | $702,361 | $341,242 | $233,724 | $146,024 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 113,164 | 113,737 | 98,209 | 96,154 | 44,718 |
| Other Non-Current Liabilities | 166,256 | 159,450 | 158,923 | 93,147 | 115,483 |
| TOTAL | $189,114 | $183,754 | $181,177 | $100,215 | $174,232 |
| Total Liabilities | $666,982 | $886,115 | $522,419 | $333,939 | $320,256 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 132,638 | 132,376 | 132,304 | 130,880 | 130,612 |
| Common Shares | 13 | 13 | 13 | 13 | 13 |
| Retained earnings | 303,528 | 380,021 | -138,600 | -663,854 | -774,282 |
| Other shareholders' equity | -7,553 | -4,805 | -1,099 | -1,307 | -1,334 |
| TOTAL | $1,952,012 | $2,001,014 | $1,431,849 | $876,274 | $737,325 |
| Total Liabilities And Equity | $2,618,994 | $2,887,129 | $1,954,268 | $1,210,213 | $1,057,581 |